Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Wayne Kuznar, Medical Writer
Authored Items
AACR’s Cancer Disparities Inaugural Report Addresses Care Inequities
Wayne Kuznar, Medical Writer
Web Exclusives
in
Disparities in Cancer Care
,
Oncology
Step-Up Therapy Program for Anti-Inflammatory Biologic Agents Does Not Increase Cost Nor Adversely Affect Patient Outcomes
Wayne Kuznar, Medical Writer
May/June 2013 Vol 6, No 4
in
Conference Highlights AMCP
Jentadueto: A New Oral Antihyperglycemic Combination Therapy for Patients with Type 2 Diabetes
Wayne Kuznar, Medical Writer
April 2013 Vol 6 No 3 Payers’ Guide to New FDA Approvals
in
Payers' Guide
,
FDA Approvals
Last modified: May 6, 2013
